About Mobidiag
Mobidiag is a company based in Espoo (Finland) founded in 2000 was acquired by Hologic in April 2021. Mobidiag has raised $16.14 million across 7 funding rounds from investors including Hologic, European Investment Bank and Business Finland. Mobidiag operates in a competitive market with competitors including Guided Therapeutics, MobileODT, Periwinkle Technologies, Zilico and Illumigyn, among others.
- Headquarter Espoo, Finland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mobidiag Oy
-
Annual Revenue
$11.13 M (USD)-67as on Sep 30, 2023
-
Net Profit
-$154.97 M (USD)-167as on Sep 30, 2023
-
EBITDA
-$154.97 M (USD)-167as on Sep 30, 2023
-
Total Equity Funding
$16.14 M (USD)
in 7 rounds
-
Latest Funding Round
$1.68 M (USD), Debt – Conventional
Jan 07, 2020
-
Investors
Hologic
& 4 more
-
Employee Count
Not available
-
Acquired by
Hologic
(Apr 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Mobidiag
Unlock access to complete
Unlock access to complete
Funding Insights of Mobidiag
Mobidiag has successfully raised a total of $16.14M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.68 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mobidiag
Mobidiag has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, European Investment Bank and Business Finland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Springvest is recognized as a leading growth investment service in Finland.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Mobidiag
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mobidiag
Investment portfolio details for Mobidiag
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mobidiag
Detailed financials for Mobidiag
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mobidiag Comparisons
Peer comparison for Mobidiag
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mobidiag
Mobidiag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guided Therapeutics, MobileODT, Periwinkle Technologies, Zilico and Illumigyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Light-based devices for cervical cancer diagnostics are developed.
|
|
| Locked | Locked | Locked |
Smartphone-based tools for cervical cancer screening are developed.
|
|
| Locked | Locked | Locked |
Developer of device for detecting cervical abnormalities
|
|
| Locked | Locked | Locked |
Real-time cancer diagnostics via Electrical Impedance Spectroscopy are developed.
|
|
| Locked | Locked | Locked |
Colonoscope for cervical cancer detection procedures is developed.
|
Detailed competitors of Mobidiag
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mobidiag
Complete news archive for Mobidiag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mobidiag
Mobidiag was founded in 2000 and raised its 1st funding round 17 years after it was founded.
Mobidiag is headquartered in Espoo, Finland.
Mobidiag is a funded company, having raised a total of $16.14M across 7 funding rounds to date.
Annual revenue of Mobidiag is $11.13M as on Sep 30, 2023.
Mobidiag was founded in 2000 in Espoo, Finland, and operates in the in vitro diagnostics sector focused on infectious diseases. Rapid multiplex PCR-based solutions, such as the Amplidiag product line, are offered for gastrointestinal infections including H. pylori, C. difficile, and various parasites, bacteria, and viruses. Instruments like Amplidiag Easy and Novodiag are utilized for diagnostics, alongside the Prove-it kits for bone, joint, and herpes conditions.
Mobidiag's top competitors include Periwinkle Technologies, Guided Therapeutics and Zilico.
Mobidiag has 5 investors. Key investors include Hologic, European Investment Bank, Business Finland, Autobio, and Springvest.